Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

“Progress in Corneal Research and Practice in Japan and Abroad”

The 23rd Annual Meeting of the Kyoto Cornea Club, November 24 and 25, 2017

Nishida, Kohji, MD, PhD*; Sotozono, Chie, MD, PhD; Yamagami, Satoru, MD, PhD; Shiraishi, Atsushi, MD, PhD§; Saika, Shizuya, MD, PhD; Fukushima, Atsuki, MD, PhD; Hori, Yuichi, MD, PhD**

doi: 10.1097/ICO.0000000000001723
Preface
Buy

*Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan;

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan;

Department of Ophthalmology, Nihon University School of Medicine, Tokyo, Japan;

§Department of Ophthalmology, Ehime University School of Medicine, Ehime, Japan;

Department of Ophthalmology, Wakayama Medical University School of Medicine, Wakayama, Japan;

Department of Ophthalmology, Kochi Medical School, Kochi, Japan; and

**Department of Ophthalmology, Toho University Omori Medical Center, Tokyo, Japan.

Correspondence: Kohji Nishida, MD, PhD, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan (email: knishida@ophthal.med.osaka-u.ac.jp).

K. Nishida has received support for travel to meetings from Santen Pharmaceutical Co, Ltd. Outside the submitted work, A. Fukushima is a board member at Santen and has received consulting fees from Kowa; lecture fees from Alcon, Santen Pharmaceutical Co, Ltd, Senju Pharmaceutical Co, Ltd, Kowa Co, Ltd, Kyowa-Kirin, Tanabe Mitsubishi, Kissei, Otsuka, AbbVie, and Eisai; and manuscript preparation fees from Alcon. A. Fukushima's institution, Kochi Medical School, jointly developed a patent (patent No. 5490477) with Nidek. Y. Hori reports grants received by Toho University Omori Medical Center from Santen Pharmaceutical Co, Ltd, HOYA, Alcon Japan, Senju Pharmaceutical Co, Ltd, and Kowa Pharmaceutical Co, Ltd. Y. Hori has received consulting fees or honoraria from Santen Pharmaceutical Co, Ltd, Otsuka Pharmaceutical Co, Ltd, and Johnson & Johnson; support for travel to meetings from Santen Pharmaceutical Co, Ltd; and, outside the submitted work, lecture fees from Santen Pharmaceutical Co, Ltd, Otsuka Pharmaceutical Co, Ltd, Alcon Japan Ltd, Senju Pharmaceutical Co, Ltd, and Kowa Pharmaceutical Co, Ltd. C. Sotozono has received lecture fees from Santen Pharmaceutical Co, Ltd, and Senju Pharmaceutical Co, Ltd, outside the submitted work. The remaining authors have no funding or conflicts of interest to declare.

Received June 29, 2018

Accepted July 01, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.